Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06887049 · ClinicalTrials.gov registry record · NA

Achieving Routine Intervention and Screening for Emotional Health

A NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
1,250
Enrollment target
1
Study location

NCT06887049 is a NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,250 participants, above the 470-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (166% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06887049, a NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
1,250 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

Interventions

  • BEHAVIORAL ARISE Learning Community Diabetes Distress Screening and Intervention
  • BEHAVIORAL ARISE Enhanced Care brief training

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 1,250 participants
Start Date 2026-03-03
Est. Completion 2028-09
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT06887049

The ClinicalTrials.gov registry entry for NCT06887049 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 470-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (166% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 2 interventions - of which ARISE Learning Community Diabetes Distress Screening and Intervention is the first listed.

NCT06887049 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06887049 about?

NCT06887049 is a clinical study titled "Achieving Routine Intervention and Screening for Emotional Health". The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).

What is the current status of trial NCT06887049?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,250 participants. The study started on 2026-03-03. Estimated completion is 2028-09.

What conditions does trial NCT06887049 study?

This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM), Diabetes Distress.

What interventions are being tested in trial NCT06887049?

The interventions under investigation include: ARISE Learning Community Diabetes Distress Screening and Intervention (BEHAVIORAL), ARISE Enhanced Care brief training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06887049?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06887049 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes Mellitus (T2DM)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.